 
|
MediFocus Guides Help Answer Key Questions about Carcinoid Tumor:
 |
What are the standard treatments for Carcinoid Tumor?
|
|
What are your treatment options?
|
|
Are there any promising new and effective treatments on the horizon?
|
|
Where can you find the doctors, hospitals, and medical centers with specialized interest and expertise in Carcinoid Tumor?
|
|
Which organizations and support groups can help you cope more effectively with Carcinoid Tumor?
|
|
|
 |
|
|
|
Medifocus Guidebook:
Carcinoid Tumor
Updated: July 14, 2008
- Comprehensive overview of
Carcinoid Tumor
- Explore your treatment options
- Learn about new developments
- Read medical journal abstracts
- Find doctors, hospitals, research centers
|
|
Carcinoid tumors belong to a larger group of tumors called neuroendocrine tumors (NET's). This broad group of tumors also includes the pancreatic islet cell tumors. Although both carcinoid and pancreatic islet cell tumors share similar morphological features, they secrete different classes of either bioactive amines or peptides, respectively. Carcinoid tumors are the most common form of NET's. The majority of carcinoids arise in the appendix and to a lesser extent in the small bowel, stomach, and duodenum whereas pancreatic islet cell tumors arise predominantly int the panreas.
Carcinoid tumors are generally quite rare. Although the majority of patients do not have symptoms associated with the tumor, when flushing and diarrhea occurs, the patient is said to have Carcinoid Syndrome. It is estimated that approximately 10% of patients with carcinoid tumors will develop the syndrome. The overall incidence of carcinoid tumors is approximately 2.0 to 2.5 per 100,000 population. The most common site for men is the small intestine whereas in women it is the appendix. A positive family history is an important risk factor of carcinoid tumors and there is an association with the development of Multiple Endocrine Neoplasia Type 1 (MEN-1). The majority of patients with NET's present in the fifth decade of life.
Depending on the clinical presentation, various imaging or endoscopic diagnostic studies may be performed. The Octreoscan is particularly useful for diagnosing the location of the tumor. Computerized tomography and/or magnetic resonance imaging are also useful to determine if liver metastases are present. Small bowel enteroscopy should be performed as well as colonoscopy for localizing the tumors. Recently, capsule endoscopy has been introduced and may permit evaluation for intestinal carcinoids.
The MediFocus Guidebook on Carcinoid Tumor contains information that is vital to anyone who has been diagnosed with this condition.
You will learn about the causes, risk factors, common signs and symptoms, medical tests that are used to establish the diagnosis, and standard treatments. You will also learn about the latest clinical advances in the management of Carcinoid Tumor as well as about the newest treatment options that are available.
The MediFocus Guidebook on Carcinoid Tumor will also inform you about important new, exciting research in the area of Carcinoid Tumor. You will also learn about the doctors, hospitals, and medical centers that are at the leading edge in conducting clinical research about Carcinoid Tumor.
Information about clinical trials, quality of life issues, a list of questions to ask your doctor, and a useful directory of organizations and support groups that can help patients with Carcinoid Tumor complete this valuable Guidebook.
You won't find this combination of information anywhere else. It is easily accessible right here. We invite you to preview the MediFocus Guidebook on Carcinoid Tumor so that you can decide if this comprehensive, trustworthy information may help you or someone you care about who has been diagnosed with Carcinoid Tumor.
|
|
